U.S. flag

An official website of the United States government

NM_000238.4(KCNH2):c.1888G>C (p.Val630Leu) AND Long QT syndrome 2

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jul 2, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002470745.2

Allele description [Variation Report for NM_000238.4(KCNH2):c.1888G>C (p.Val630Leu)]

NM_000238.4(KCNH2):c.1888G>C (p.Val630Leu)

Gene:
KCNH2:potassium voltage-gated channel subfamily H member 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q36.1
Genomic location:
Preferred name:
NM_000238.4(KCNH2):c.1888G>C (p.Val630Leu)
HGVS:
  • NC_000007.14:g.150951505C>G
  • NG_008916.1:g.31422G>C
  • NM_000238.4:c.1888G>CMANE SELECT
  • NM_001204798.2:c.868G>C
  • NM_001406753.1:c.1600G>C
  • NM_001406755.1:c.1711G>C
  • NM_001406756.1:c.1600G>C
  • NM_001406757.1:c.1588G>C
  • NM_172056.3:c.1888G>C
  • NM_172057.3:c.868G>C
  • NP_000229.1:p.Val630Leu
  • NP_000229.1:p.Val630Leu
  • NP_001191727.1:p.Val290Leu
  • NP_001393682.1:p.Val534Leu
  • NP_001393684.1:p.Val571Leu
  • NP_001393685.1:p.Val534Leu
  • NP_001393686.1:p.Val530Leu
  • NP_742053.1:p.Val630Leu
  • NP_742053.1:p.Val630Leu
  • NP_742054.1:p.Val290Leu
  • NP_742054.1:p.Val290Leu
  • LRG_288t1:c.1888G>C
  • LRG_288t2:c.1888G>C
  • LRG_288t3:c.868G>C
  • LRG_288:g.31422G>C
  • LRG_288p1:p.Val630Leu
  • LRG_288p2:p.Val630Leu
  • LRG_288p3:p.Val290Leu
  • NC_000007.13:g.150648593C>G
  • NM_000238.3:c.1888G>C
  • NM_172056.2:c.1888G>C
  • NM_172057.2:c.868G>C
  • NR_176254.1:n.2296G>C
  • NR_176255.1:n.1169G>C
  • Q12809:p.Val630Leu
Protein change:
V290L
Links:
UniProtKB: Q12809#VAR_008934; dbSNP: rs199472958
NCBI 1000 Genomes Browser:
rs199472958
Molecular consequence:
  • NM_000238.4:c.1888G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001204798.2:c.868G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406753.1:c.1600G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406755.1:c.1711G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406756.1:c.1600G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406757.1:c.1588G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_172056.3:c.1888G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_172057.3:c.868G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Long QT syndrome 2 (LQT2)
Identifiers:
MONDO: MONDO:0013367; MedGen: C3150943; Orphanet: 101016; Orphanet: 768; OMIM: 613688

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002766607Victorian Clinical Genetics Services, Murdoch Childrens Research Institute

See additional submitters

criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Jul 2, 2020)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Four novel KVLQT1 and four novel HERG mutations in familial long-QT syndrome.

Tanaka T, Nagai R, Tomoike H, Takata S, Yano K, Yabuta K, Haneda N, Nakano O, Shibata A, Sawayama T, Kasai H, Yazaki Y, Nakamura Y.

Circulation. 1997 Feb 4;95(3):565-7.

PubMed [citation]
PMID:
9024139

Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and KCNE1.

Splawski I, Shen J, Timothy KW, Vincent GM, Lehmann MH, Keating MT.

Genomics. 1998 Jul 1;51(1):86-97.

PubMed [citation]
PMID:
9693036
See all PubMed Citations (6)

Details of each submission

From Victorian Clinical Genetics Services, Murdoch Childrens Research Institute, SCV002766607.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

Based on the classification scheme VCGS_Germline_v1.3.3, this variant is classified as likely pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with long QT syndrome type 2. (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0112 - The condition associated with this gene has incomplete penetrance (GeneReviews). (I) 0200 - Variant is predicted to result in a missense amino acid change from valine to leucine. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (v2) (7 heterozygotes, 0 homozygotes). (I) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. Highly conserved, minor amino acid change. (SP) 0600 - Variant is located in the annotated pore domain (PDB). (I) 0703 – Other missense variants comparable to the one identified in this case have moderate previous evidence for pathogenicity. p.(Val630Ile) has two likely pathogenic entries in ClinVar and has been classified as pathogenic in a sudden arrhythmic death patient (PMID: 28449774). p.(Val630Ala) has been reported in two LQTS patients, one being de novo (PMID: 15840476, 9693036). (SP) 0803 - This variant has limited previous evidence of pathogenicity in an unrelated individuals. This variant has been identified in a Japanese LQTS patient (PMID: 9024139) and has one ClinVar entry (no classification provided). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1002 - This variant has moderate functional evidence supporting abnormal protein function. Functional evidence shows that this variant decreases slope conductance and negatively shifts steady-state inactivation (PMID: 9721698). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024